UPC_CFI_768/2025

FUNCTIONALIZED PEPTIDES AS ANTIVIRAL AGENTS

InfringementMain Infringement ActionMunich LDInfringementWritten Phase

Overview Decisions Documents Timeline

Parties

Claimants

Enanta Pharmaceuticals, Inc.

Respondents

Pfizer, Inc.
C.P. Pharmaceuticals International C.V.
Pfizer Europe MA EEIG
Pfizer Manufacturing Deutschland GmbH
Pfizer Italia S.r.L.
Pfizer Ireland Pharmaceuticals Unlimited Company
Pfizer Corporation Austria Gesellschaft m.b.H
Pfizer nv/SA
Pfizer Luxembourg S.a.r.l.
Pfizer Aps
Pfizer Oy
Pfizer SAS
Pfizer Pharma GmbH
Pfizer S.r.l.
Pfizer B.V.
Laboratórios Pfizer, Lda.
Pfizer Romania S.R.L.
Pfizer AB

Judges

Daniel Voss
Georg Werner
Rute Lopes
Rudi Goedeweeck

Patents

EP4051265

CPC codes: A61K31/4155, C07D403/14, A61P31/14, A61K31/454, A61K31/403, C07D403/12, C07K5/0202, C07K5/06, C07K5/06165, C07K5/0823, C07D405/14, A61K31/404…

Technology area: Pharmaceuticals · Antiviral

Sector: Organic Chemistry

Outcome

—

Filed: Aug 20, 2025

First decided: —

Language: English

Open on UPC Registry